User
0
Your Cart Item

₹ 0.00

0 Test(s)

Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test NTRK1/2/3 Gene Fusions Test by NGS is typically 14-21 days from the receipt of the sample in the laboratory.

What are the prerequisites for the test NTRK1/2/3 Gene Fusions Test by NGS

  • Specimen Type: Formalin-fixed, paraffin-embedded tissue block or at least 10 unstained slides
  • Specimen Stability: Specimens should be received within 5 days of collection
  • Specimen Storage: Specimens should be stored at room temperature
  • Specimen Transport: Specimens should be transported at room temperature
  • Rejection Criteria: Insufficient specimen volume, improper specimen storage or transport

What are the measure values for the test NTRK1/2/3 Gene Fusions Test by NGS

  • NTRK1 Gene Fusions: Detected or Not Detected
  • NTRK2 Gene Fusions: Detected or Not Detected
  • NTRK3 Gene Fusions: Detected or Not Detected

What does this test NTRK1/2/3 Gene Fusions Test by NGS identify?

  • This test identifies fusion events involving the NTRK1, NTRK2, and NTRK3 genes.
  • It uses Next-Generation Sequencing (NGS) technology to detect these gene fusions.
  • Gene fusions involving NTRK genes can lead to constitutive activation of the NTRK signaling pathway, which can drive tumorigenesis in certain cancers.
  • Identification of NTRK gene fusions can help guide treatment decisions, as targeted therapies such as TRK inhibitors may be effective in patients with these fusions.

Why is this test NTRK1/2/3 Gene Fusions Test by NGS taken?

  • Identification of NTRK1/2/3 Gene Fusions: This test is taken to identify the presence of NTRK1/2/3 gene fusions, which are genetic alterations that can drive the growth of certain types of cancer.
  • Predicting Response to Targeted Therapies: Knowing the status of NTRK1/2/3 gene fusions can help healthcare providers determine if a patient is eligible for targeted therapies that specifically target these genetic abnormalities.
  • Prognostic Information: The results of this test can provide valuable prognostic information that may guide treatment decisions and help predict the outcome of the disease.
  • Personalized Medicine: Identifying NTRK1/2/3 gene fusions through this test allows for personalized treatment approaches, tailored to the individual genetic profile of the patient.

Popular FAQs on Test

The NTRK1/2/3 Gene Fusions Test by NGS is a genetic test that uses next-generation sequencing (NGS) technology to detect fusion events involving the NTRK1, NTRK2, and NTRK3 genes. These gene fusions can be important in identifying potential targeted therapy options for certain types of cancers.
The NTRK1/2/3 Gene Fusions Test is important because it can help identify patients who may benefit from targeted therapies that specifically target the NTRK1, NTRK2, or NTRK3 gene fusions. These targeted therapies have shown promising results in treating cancers with these specific genetic abnormalities.
The NTRK1/2/3 Gene Fusions Test is performed using next-generation sequencing (NGS) technology on a tissue sample from the patient's tumor. The NGS technology allows for the detection of gene fusions involving the NTRK1, NTRK2, and NTRK3 genes with high sensitivity and specificity.
Patients with certain types of cancers, such as non-small cell lung cancer, colorectal cancer, or certain types of sarcomas, may benefit from the NTRK1/2/3 Gene Fusions Test. It is recommended for patients who have exhausted standard treatment options or have tumors that have specific characteristics that may indicate NTRK gene fusions.
The potential benefits of the NTRK1/2/3 Gene Fusions Test include identifying targeted therapy options that specifically address the genetic abnormalities present in the tumor. This can lead to more personalized and effective treatment strategies for patients with NTRK1, NTRK2, or NTRK3 gene fusions.

Customer Google Rating

2 week ago

Being the sole breadwinner, I was worried about my aging parents. UHL health plan provided the ideal coverage with additional benefits like fastest claim settlement .

Rahul Kashyap People

2 week ago

Choosing UHL HEALTH PLANS felt like an adventure. The website guided me smoothly and I was thrilled with the ease of comparison. Cheers UHL. The website guided me smoothly

Adarsh Kumar People

4 weeks ago

Having UHL heath plan which is so beneficial and the investment is also low. Service provided is quick and on time. Online renewals are made so simple through online portal service.

Kushagra People

2 week ago

I got the UHL Health Plan at a low cost, and the coverage is as high as promised. The service is excellent, and their staff is available 24/7 to assist with any inquiries.

Mahima Pandey People

2 week ago

I’m securing my future by investing in the UHL Health Plan and opting for their retirement health plans. In my opinion, it’s the best investment, as the policy covers 92% of my healthcare needs.

Ajeet People

1 week ago

The claims process is easy due to the fast service provided by their dedicated staff. Plus, it offers tax-saving benefits, which is another great advantage. I'm very satisfied with it.

Chitransh Trivedi People

1 week ago

I purchased the UHL Health Plan, opting for their term health coverage. The premiums are affordable, around Rs. 10K per year, making it a great option for my budget.

Tushar People

2 week ago

I have the UHL Health Plan for my family of four, and it has proven to be reliable with many benefits and great returns on investment. The policy coverage is around 90%.

Naina Verma People

2 week ago

I’m securing my future by investing in the UHL Health Plan and opting for their retirement health plans. In my opinion, it’s the best investment, as the policy covers 92% of my healthcare needs.

Anil People